Expertise in
1
conditions

Hongxing Pan

National Health Commission Key Laboratory Of Enteric Pathogenic Microbiology, 
Nanjing, CN 
Expertise in
1
conditions
National Health Commission Key Laboratory Of Enteric Pathogenic Microbiology, 
Nanjing, CN 

Overview

Hongxing Pan practices practicing medicine in Nanjing, China.

Pan is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Severe Acute Respiratory Syndrome (SARS), Chickenpox, Plague, and COVID-19.

They are actively involved in clinical research, co-authoring 37 peer reviewed articles and participating in 2 clinical trials.

Locations

National Health Commission Key Laboratory Of Enteric Pathogenic Microbiology, Nanjing, China
Other Locations
Beijing, 100714, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized and Controlled Ⅳ Clinical Trial to Evaluate the Immunogenicity and Safety of COVID-19 Vaccine (Vero Cell), Inactivated Co-administrated With EV71 Vaccine (Vero Cell) in Children Aged 3-5 Years Old
A Randomized and Controlled Ⅳ Clinical Trial to Evaluate the Immunogenicity and Safety of COVID-19 Vaccine (Vero Cell), Inactivated Co-administrated With EV71 Vaccine (Vero Cell) in Children Aged 3-5 Years Old
Enrollment Status: Completed
Publish Date: October 10, 2023
Intervention Type: Biological
Study Phase: Phase 4
A Phase IV Randomized, Blinded Clinical Trial to Assess Measles Mumps and Rubella Combined Vaccine, Live, (MMR) Lot-to-lot Consistency in Healthy Chinese Children at the Age of 8-12 Months
A Phase IV Randomized, Blinded Clinical Trial to Assess Measles Mumps and Rubella Combined Vaccine, Live, (MMR) Lot-to-lot Consistency in Healthy Chinese Children at the Age of 8-12 Months
Enrollment Status: Completed
Publish Date: August 14, 2023
Intervention Type: Biological
Study Phase: Phase 4
View 1 Less Clinical Trial

37 Total Publications

Safety Profiles of Seasonal Influenza Vaccines in Chinese Children and Adolescents: A Pooled Analysis of Five Clinical Studies.
Safety Profiles of Seasonal Influenza Vaccines in Chinese Children and Adolescents: A Pooled Analysis of Five Clinical Studies.
Journal: Infectious diseases and therapy
Published: May 16, 2026

Frequently Asked Questions about Hongxing Pan

Is Hongxing Pan a top-rated expert for Severe Acute Respiratory Syndrome (SARS)?

MediFind is an objective health platform that identifies experts based on real-world data. Hongxing Pan is classified as an Advanced expert for Severe Acute Respiratory Syndrome (SARS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Hongxing Pan participate in research or clinical trials?

Yes. Hongxing Pan has published 37 articles and abstracts on conditions like Severe Acute Respiratory Syndrome (SARS). You can view a list of Hongxing Pan's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Pan's expertise for a condition
ConditionClose
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile